As this issue goes to press, the country is witnessing the inauguration of new President Barack Obama, who has an established track record of supporting personalized medicine—the topic of this month’s cover story. In his inaugural add
Read MoreSome genomic tests developed to personalize medical decisions about cancer care are beneficial, while for others the evidence is uncertain and reliance on the test might even lead to poorer medical management of cancer in some cases.
Read More
More than 1,600 genetic tests are currently available
Read MoreCombiMatrix Corporation announces that its wholly owned subsidiary, Combimatrix Molecular Diagnostics, has entered into a new partnership with Lenetix, a New York based laboratory, to co-market CMDXs suite of array CGH based tests.
Read MoreNew analyses show that genetic testing used to guide initial dosing of the blood-thinner warfarin may not be cost-effective for typical patients with atrial fibrillation but may be for patients at higher risk for major bleeding.
Read More